WE HAVE A VISION*

for Liberating Clinicians to Stop Patient Deterioration

 

GE Healthcare and Roche Diagnostics are bringing together our experience in the clinical care setting and in the lab to address one of the most significant challenges in healthcare. We envision a digital platform that uses artificial intelligence to empower clinicians to detect patient deterioration before it’s too late. Our first target is sepsis.

Sepsis is the #1 cause of death in hospitals today¹

Sepsis hospitalization costs more than $27B/Year in the United States²

Up to 80% of sepsis deaths are preventable³

Up to 49% of clinician time is spent interacting with the EMR.⁴

 

Early indicators of sepsis can often be missed and patient risk status can change rapidly.

 

GE Healthcare & Roche Diagnostics are uniquely positioned to predict deterioration and optimize care:

 

Clinically |  Operationally  |  Economically

GE Healthcare and Roche Diagnostics are working together on an answer to the tragedy of patient deaths related to undetected deterioration. An intuitive “digital team member” could provide a continuous clinical view of each patient. As designed, it would synthesize all available vitals and data from many sources, helping make patient information more relevant and easily accessible to clinicians.

 

 

Imagine if clinicians could have:

Envision a technology that turns vast quantities of data into useful in-context insights, in near real time. All based on continuous updates from the system of record.

As designed, Natural Language Processing would recognize the clinician’s train of thought, query the data and quickly present the relevant clinical information. Speaking your language and helping you discern a more precise treatment pathway for each patient.

our vision is to liberate clinicians and improve collaboration, giving more control and inspiring confidence as you work to identify and treat the deteriorating patient.

 

Contact Our Team  to find out how you can join the fight against patient deterioration.

SHM - Hospital Medicine 2019

 

March 24-27, 2019 | National Harbor, Maryland

Gaylord National Resort & Convention Center

GE Booth #1115

1. Sepsis Fact Sheet, “Healthcare Cost and Utilization Project (HCUP) Statistical Briefs, Septicemia in U.S. Hospitals”. Sepsis Alliance.

 

2. Sepsis Fact Sheet, “Healthcare Cost and Utilization Project (HCUP) Statistical Briefs, Septicemia in U.S. Hospitals”. Sepsis Alliance.

 

3. Zanotti-Cavazzoni, S.l. “Duration of Hypotension before Initiation of Effective Antimicrobial Therapy Is the Critical Determinant of Survival in Human Septic Shock.” Yearbook of Critical Care Medicine, vol. 2007, 2007, pp. 187–188., doi:10.1016/s0734-3299(08)70339-3.

 

4. Ofri, D. (2017, November 17). The Patients vs. Paperwork Problem for Doctors. The New York Times.

 

 

*Disclaimer: Technology in development that represents ongoing research and development efforts. These technologies are not products and may never become products. Not for sale. Not cleared or approved by the U.S. FDA or any other global regulator for commercial availability.